Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer

Cancer Letters

Volumn 334, Issue 2, 2013, Pages 338-345

  Yang, Xiao yan ^a   Li, Yun xia ^b   Li, Min ^a   Zhang, Li ^b   Feng, Li xia ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

^b Ji'nan Second Municipal Hospital   (China)

Author keywords

CD44; Hyaluronic acid; Nanostructured lipid carriers; Paclitaxel; Tumor target

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; ELECTROSTATIC ATTRACTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; STATIC ELECTRICITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COLONIC NEOPLASMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HCT116 CELLS; HUMANS; HYALURONIC ACID; LIPIDS; MELANOMA, EXPERIMENTAL; MICE; NANOSTRUCTURES; PACLITAXEL; RANDOM ALLOCATION;

MUS;

EID: 84878216928     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.07.002     Document Type: Article

References (24)

1. Othman T., Goto S., Lee J.B., Taimura A., Matsumoto T., Kosaka M. Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel. Pharmacology 2001, 62:208-212.
2. Xin D.C., Wang Y., Xiang J.N. The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency. Pharm. Res. 2010, 27:380-389.
3. Journo-Gershfeld G., Kapp D., Shamay Y., Kopecek J., David A. Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma. Pharm. Res. 2012, 29:1121-1133.
4. Weiss R.B., Donehower R.C., Wiernik P.H., Ohnuma T., Gralla R.J., Trump D.L., Baker J.R., Van Echo D.A., Von Hoff D.D., Leyland-Jones B. Hypersensitivity reactions from taxol. J. Clin. Oncol. 1990, 8:1263-1268.
5. Singla A.K., Garg A., Aggarwal D. Paclitaxel and its formulations. Int. J. Pharm. 2002, 235:179-192.
6. Rivkin I., Cohen K., Koffler J., Melikhov D., Peer D., Margalit R. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 2010, 31:7106-7114.
7. Zhao P.Q., Wang H.J., Yu M., Cao S.Z., Zhang F., Chang J., Niu R.F. Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation. Pharm. Res. 2010, 27:1914-1926.
8. Zhan C.Y., Gu B., Xie C., Li J., Liu Y., Lu W.Y. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J. Control Release 2010, 143:136-142.
9. Danhier F., Vroman B., Lecouturier N., Crokart N., Pourcelle V., Freichels H., Jerome C., Marchand-Brynaert J., Feron O., Preat V. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J. Control Release 2009, 140:166-173.
10. Heo D.N., Yang D.H., Moon H.J., Lee J.B., Bae M.S., Lee S.C., Lee W.J., Sun I.C., Kwon I.K. Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials 2012, 33:856-866.
11. De Stefano I., Battaglia A., Zannoni G.F., Prisco M.G., Fattorossi A., Travaglia D., Baroni S., Renier D., Scambia G., Ferlini C., Gallo D. Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. Cancer Chemother. Pharmacol. 2011, 68:107-116.
12. Ossipov D.A. Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert. Opin. Drug. Deliv. 2010, 7:681-703.
13. Liu D.H., Liu Z.H., Wang L.L., Zhang C., Zhang N. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf. B. Biointerfaces 2011, 85:262-269.
14. Liu D.H., Zhang N. Cancer chemotherapy with lipid-based nanocarriers. Crit. Rev. Ther. Drug. Carrier Syst. 2010, 27:371-417.
15. Zhang X.G., Miao J., Dai Y.Q., Du Y.Z., Yuan H., Hu F.Q. Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int. J. Pharm. 2008, 361:239-244.
16. Wang M.T., Jin Y, Yang Y.X., Zhao C.Y., Yang H.Y., Xu X.F., Qin X, Wang Z.D., Zhang Z.R., Jian Y.L., Huang Y In vivo biodistribution anti-inflammatory and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system. Int. J. Nanomedicine 2010, 5:487-497.
17. Liu D.H., Liu F.X., Liu Z.H., Wang L.L., Zhang N. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol. Pharm. 2011, 8:2291-2301.
18. Jiang X.Y., Xin H.L., Sha X.Y., Gu J.J., Jiang Y., Law K., Chen Y.Z., Chen L.C., Wang X., Fang X.L. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation. Int. J. Pharm. 2011, 420:385-394.
19. Park K., Lee M.Y., Kim K.S., Hahn S.K. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 2010, 31:5258-5265.
20. Lee H., Mok H., Lee S., Oh Y.K., Park T.G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J. Control Release 2007, 119:245-252.
21. Ito T., Yoshihara C., Hamada K., Koyama Y. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 2010, 31:2912-2918.
22. Zheng D.H., Li X.L., Xu H., Lu X.W., Hu Y., Fan W.X. Study on docetaxel-loaded nanoparticles with high antitumor efficacy against malignant melanoma. Acta Biochim. Biophys. Sin. 2009, 41:578-587.
23. Kim T.G., Lee H., Jang Y., Park T.G. Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel. Biomacromolecules 2009, 10:1532-1539.
24. Nasti A., Zaki N.M., de Leonardis P., Ungphaiboon S., Sansongsak P., Rimoli M.G., Tirelli N. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm. Res. 2009, 26:1918-1930.